Sector | Healthcare | Compare with Sector peers |
Industry | Hospital & Healthcare Services | Compare with Industry peers |
Website | http://www.dragarwal.com | |
Market Cap | 1,457.00 Cr. | |
Enterprise Value(EV) | 1,463.72 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 100.53 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 30.84 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 65.35 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 311.55 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 10.06 | Calculated using Price: 3,133.80 |
Dividend Yield | 0.10 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.47 Cr. | 4,700,000 Shares |
FaceValue | 10 | |
About Dr Agarwals Eye Hospital Ltd. | ||
Dr.Agarwal's Eye Hospital has been promoted by Dr.J.Agarwal and his family members in 1994. Though the entire family has been in the profession of providing total eye care solutions for almost five decades prior to this, through various private limited company and partnership firms, owned by the family members. The Hospital has always been at the forefront of every medical advancement in the field of Ophthalmic care in the world and has several firsts to its credit. The Hospital is engaged in conducting continuous training and research and development programs and has over a period, developed an excellent team of highly skilled Ophthalmic specialists and surgeons, to assist in its growth plans. |
1 Day |
|
+0.75% |
1 Week |
|
+5.01% |
1 Month |
|
-4.54% |
3 Month |
|
+10.54% |
6 Month |
|
+33.45% |
1 Year |
|
+227.91% |
2 Year |
|
+328.67% |
5 Year |
|
+770.50% |
10 Year |
|
+4192.88% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 26.67 | 0.16 | 27.78 | 21.02 | 29.55 | 26.91 | -2.6 | 36.29 | 38.56 | |
Return on Capital Employed (%) | 18.81 | 7.7 | 28.26 | 31.7 | 34.3 | 39.87 | 16.92 | 42.4 | 42.98 | |
Return on Assets (%) | 8.53 | 0.05 | 8.87 | 7.65 | 11.01 | 9.55 | -0.86 | 9.63 | 9.78 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 24 | 23 | 29 | 35 | 46 | 56 | 55 | 78 | 113 | 137 | |
Non Curr. Liab. | 13 | 25 | 24 | 24 | 40 | 71 | 42 | 173 | 212 | 217 | |
Curr. Liab. | 31 | 36 | 27 | 37 | 35 | 39 | 70 | 82 | 96 | 63 | |
Minority Int. | |||||||||||
Equity & Liab. | 67 | 84 | 81 | 96 | 120 | 166 | 167 | 333 | 422 | 417 | |
Non Curr. Assets | 44 | 61 | 61 | 73 | 91 | 136 | 123 | 283 | 375 | 358 | |
Curr. Assets | 23 | 24 | 20 | 23 | 30 | 30 | 44 | 50 | 47 | 59 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 67 | 84 | 81 | 96 | 120 | 166 | 167 | 333 | 422 | 417 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 118 | 137 | 149 | 153 | 170 | 176 | 140 | 201 | 268 | 306 | |
Other Income | 0 | 0 | 2 | 2 | 2 | 3 | 2 | 1 | 2 | 5 | |
Total Income | 118 | 137 | 150 | 156 | 172 | 179 | 142 | 202 | 270 | 311 | |
Total Expenditure | -103 | -121 | -126 | -129 | -140 | -129 | -110 | -143 | -192 | -220 | |
PBIDT | 15 | 15 | 24 | 27 | 32 | 50 | 32 | 60 | 78 | 91 | |
Interest | -4 | -5 | -4 | -3 | -4 | -9 | -7 | -7 | -8 | -7 | |
Depreciation | -6 | -11 | -9 | -10 | -11 | -21 | -19 | -20 | -20 | -21 | |
Taxation | 0 | 1 | -4 | -7 | -6 | -6 | -7 | -8 | -12 | -16 | |
Exceptional Items | |||||||||||
PAT | 6 | 0 | 7 | 7 | 12 | 14 | -1 | 24 | 37 | 47 | |
Adjusted EPS | 12 | 0 | 16 | 14 | 25 | 29 | -3 | 51 | 79 | 101 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 12 | 14 | 17 | 20 | 19 | 25 | 39 | 34 | 57 | 70 | |
Cash Fr. Inv. | -11 | -10 | -17 | -8 | -11 | -25 | -17 | -11 | -46 | -71 | |
Cash Fr. Finan. | -3 | -5 | 0 | -12 | -8 | 2 | -20 | -8 | -4 | 0 | |
Net Change | -3 | -1 | 0 | 0 | 0 | 2 | 2 | 15 | 7 | -1 | |
Cash & Cash Eqvt | 3 | 1 | 2 | 2 | 2 | 4 | 6 | 22 | 28 | 27 |
Wed, 27 Mar 2024
Closure of Trading Window Disclosure of closure of the trading window is submitted. |
Wed, 27 Mar 2024
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 Disclosure of commencement of operation of new units is submitted. |
Fri, 22 Mar 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Disclosure under Regulation 39(3) of the SEBI (LODR) Regulations 2015 is submitted. |
Wed, 27 Mar 2024 |
High Delivery Percentage |
Opening at High |
Close Within 52 Week High Zone |
Opening at High for 2 Days |
High Decrease in 1 Month |